Related references
Note: Only part of the references are listed.Requirement of biphasic calcium release from the endoplasmic reticulum for Fas-mediated apoptosis
Ann L. Wozniak et al.
JOURNAL OF CELL BIOLOGY (2006)
Hydroxylated xestospongins block inositol-1,4,5-trisphosphate-induced Ca2+ release and sensitize Ca2+-induced Ca2+-release mediated by ryanodine receptors
TA Ta et al.
MOLECULAR PHARMACOLOGY (2006)
Fas ligand promotes tumor immune evasion of colon cancer in vivo
AE Ryan et al.
CELL CYCLE (2006)
Addressing the Fas counterattack controversy:: Blocking Fas ligand expression suppresses tumor immune evasion of colon cancer in vivo
AE Ryan et al.
CANCER RESEARCH (2005)
Tumor counterattack: fact or fiction?
FH Igney et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
K Yamana et al.
BRITISH JOURNAL OF CANCER (2005)
A peptide inhibitor of cytochrome c/inositol 1,4,5-trisphosphate receptor binding blocks intrinsic and extrinsic cell death pathways
D Boehning et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The Fas signalling pathway and its role in the pathogenesis of cancer
A Houston et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis
D Boehning et al.
NATURE CELL BIOLOGY (2003)
Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
A Houston et al.
BRITISH JOURNAL OF CANCER (2003)
Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo
A Houston et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The biological role of the Fas/FasL system during tumor formation and progression
E Reichmann
SEMINARS IN CANCER BIOLOGY (2002)
Tumour Fas ligand: Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer
T Reimer et al.
BREAST CANCER RESEARCH (2002)
Fas ligand upregulation is an early event in colonic carcinogenesis
MW Bennett et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
Share Paper
